FMP
NASDAQ
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
7.13 USD
0.08 (1.12%)
Valuation Date:
May 6, 2024 4:00 PM
Share Price on Valuation Date
$7.13
Stock Beta
0.884
Shares Outstanding
1042415